Steroid Receptor RNA Activator Protein (SRAP): A potential new prognostic marker for estrogen receptor-positive/node-negative/younger breast cancer patients

Breast Cancer Research

Volumn 11, Issue 5, 2009, Pages

  Yan, Yi ^a,b   Skliris, George P ^a,b   Penner, Carla ^b   Chooniedass Kothari, Shilpa ^a,b   Cooper, Charlton ^b   Nugent, Zoann ^a   Blanchard, Anne ^b   Watson, Peter H ^c   Myal, Yvonne ^b   Murphy, Leigh C ^a,b   Leygue, Etienne ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; PROGESTERONE RECEPTOR; PROTEIN; PROTEIN ANTIBODY; STEROID RECEPTOR RNA ACTIVATOR PROTEIN; UNCLASSIFIED DRUG; ESTROGEN RECEPTOR; STEROID RECEPTOR RNA ACTIVATOR; TUMOR MARKER; UNTRANSLATED RNA;

ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; OUTCOME ASSESSMENT; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; RECURRENCE RISK; TISSUE MICROARRAY; BIOSYNTHESIS; BREAST TUMOR; GENETICS; METABOLISM; METHODOLOGY; MICROARRAY ANALYSIS; PATHOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MICROARRAY ANALYSIS; RECEPTORS, ESTROGEN; RNA, UNTRANSLATED; TUMOR MARKERS, BIOLOGICAL;

EID: 76849105477     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2359     Document Type: Article

References (36)

1. Porter P. "Westernizing" women's risks? Breast cancer in lower-income countries. N Engl J Med 2008, 358:213-216. 10.1056/NEJMp0708307, 18199859.
2. Goldhirsch A, Glick JH, Gelber RD, Coates AS, Senn HJ. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol 2001, 19:3817-3827.
3. Ross JS, Fletcher JA, Linette GP, Stec J, Clark E, Ayers M, Symmans WF, Pusztai L, Bloom KJ. The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy. Oncologist 2003, 8:307-325. 10.1634/theoncologist.8-4-307, 12897328.
4. Abd El-Rehim DM, Ball G, Pinder SE, Rakha E, Paish C, Robertson JF, Macmillan D, Blamey RW, Ellis IO. High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int J Cancer 2005, 116:340-350. 10.1002/ijc.21004, 15818618.
5. Gruvberger-Saal SK, Cunliffe HE, Carr KM, Hedenfalk IA. Microarrays in breast cancer research and clinical practice--the future lies ahead. Endocr Relat Cancer 2006, 13:1017-1031. 10.1677/erc.1.01246, 17158752.
6. Dowsett M, Dunbier AK. Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer. Clin Cancer Res 2008, 14:8019-8026. 10.1158/1078-0432.CCR-08-0974, 19088018.
7. Lanz RB, McKenna NJ, Onate SA, Albrecht U, Wong J, Tsai SY, Tsai MJ, O'Malley BW. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 1999, 97:17-27. 10.1016/S0092-8674(00)80711-4, 10199399.
8. Caretti G, Lei EP, Sartorelli V. The DEAD-box p68/p72 proteins and the noncoding RNA steroid receptor activator SRA: eclectic regulators of disparate biological functions. Cell Cycle 2007, 6:1172-1176.
9. Colley SM, Iyer KR, Leedman PJ. The RNA coregulator SRA, its binding proteins and nuclear receptor signaling activity. IUBMB Life 2008, 60:159-164. 10.1002/iub.22, 18380007.
10. Leygue E. Steroid Receptor RNA activator (SRA1): unusual bi-faceted gene products with suspected relevance to breast cancer. Nucl Recept Signal 2007, 5:e006. 17710122, 1948073.
11. Hussein-Fikret S, Fuller PJ. Expression of nuclear receptor coregulators in ovarian stromal and epithelial tumours. Mol Cell Endocrinol 2005, 229:149-160. 10.1016/j.mce.2004.08.005, 15607539.
12. Lanz RB, Chua SS, Barron N, Soder BM, DeMayo F, O'Malley BW. Steroid receptor RNA activator stimulates proliferation as well as apoptosis in vivo. Mol Cell Biol 2003, 23:7163-7176. 10.1128/MCB.23.20.7163-7176.2003, 230309, 14517287.
13. Leygue E, Dotzlaw H, Watson PH, Murphy LC. Expression of the steroid receptor RNA activator in human breast tumors. Cancer Res 1999, 59:4190-4193.
14. Murphy LC, Simon SLR, Parkes A, Leygue E, Dotzlaw H, Snell L, Troup S, Adeyinka A, Watson PH. Altered expression of estrogen receptor coregulators during human breast tumorigenesis. Cancer Res 2000, 60:6266-6271.
15. Chooniedass-Kothari S, Emberley E, Hamedani MK, Troup S, Wang X, Czosnek A, Hube F, Mutawe M, Watson PH, Leygue E. The steroid receptor RNA activator is the first functional RNA encoding a protein. Febs Letters 2004, 566:43-47. 10.1016/j.febslet.2004.03.104, 15147866.
16. Emberley E, Huang GJ, Hamedani MK, Czosnek A, Ali D, Grolla A, Lu B, Watson PH, Murphy LC, Leygue E. Identification of new human coding steroid receptor RNA activator isoforms. Biochemical and Biophysical Research Communications 2003, 301:509-515. 10.1016/S0006-291X(02)03070-X, 12565891.
17. Hube F, Guo JM, Chooniedass-Kothari S, Cooper C, Hamedani MK, Dibrov AA, Blanchard AAA, Wang XM, Deng G, Myal Y, Leygue E. Alternative splicing of the first intron of the steroid receptor RNA activator (SRA) participates in the generation of coding and noncoding RNA isoforms in breast cancer cell lines. DNA and Cell Biology 2006, 25:418-428. 10.1089/dna.2006.25.418, 16848684.
18. Kawashima H, Takano H, Sugita S, Takahara Y, Sugimura K, Nakatani T. A novel steroid receptor co-activator protein (SRAP) as an alternative form of steroid receptor RNA-activator gene: expression in prostate cancer cells and enhancement of androgen receptor activity. Biochem J 2003, 369:163-171. 10.1042/BJ20020743, 1223065, 12350225.
19. Kurisu T, Tanaka T, Ishii J, Matsumura K, Sugimura K, Nakatani T, Kawashima H. Expression and function of human steroid receptor RNA activator in prostate cancer cells: role of endogenous hSRA protein in androgen receptor mediated transcription. Prostate Cancer and Prostatic Diseases 2006, 9:173-178. 10.1038/sj.pcan.4500867, 16607388.
20. Fuller-Pace FV. DExD/H box RNA helicases: multifunctional proteins with important roles in transcriptional regulation. Nucleic Acids Res 2006, 34:4206-4215. 10.1093/nar/gkl460, 1616952, 16935882.
21. Jung SY, Malovannaya A, Wei J, O'Malley BW, Qin J. Proteomic Analysis of Steady-State Nuclear Hormone Receptor Coactivator Complexes. Mol Endocrinol 2005, 19:2451-2465. 10.1210/me.2004-0476, 16051665.
22. Cooper C, Guo J, Yan Y, Chooniedass-Kothari S, Hube F, Hamedani MK, Murphy LC, Myal Y, Leygue E. Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotides. Nucleic Acids Res 2009, 37:4518-4531. 10.1093/nar/gkp441, 2715257, 19483093.
23. Miksicek RJ, Myal Y, Watson PH, Walker C, Murphy LC, Leygue E. Identification of a novel breast- and salivary gland-specific, mucin-like gene strongly expressed in normal and tumor human mammary epithelium. Cancer Res 2002, 62:2736-2740.
24. Watson PH, Snell L, Parisien M. The NCIC-Manitoba Breast Tumor Bank: a resource for applied cancer research. CMAJ 1996, 155:281-283. 1487994, 8705906.
25. Skliris GP, Hube F, Gheorghiu I, Mutawe MM, Penner C, Watson PH, Murphy LC, Leygue E, Myal Y. Expression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancers. Histopathology 2008, 52:355-369. 10.1111/j.1365-2559.2007.02955.x, 2253716, 18269587.
26. Skliris GP, Leygue E, Curtis-Snell L, Watson PH, Murphy LC. Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours. Br J Cancer 2006, 95:616-626. 10.1038/sj.bjc.6603295, 2360679, 16880783.
27. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991, 19:403-410. 10.1111/j.1365-2559.1991.tb00229.x, 1757079.
28. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174. 10.2307/2529310, 843571.
29. Lanz RB, Razani B, Goldberg AD, O'Malley BW. Distinct RNA motifs are important for coactivation of steroid hormone receptors by steroid receptor RNA activator (SRA). Proc Natl Acad Sci USA 2002, 99:16081-16086. 10.1073/pnas.192571399, 138568, 12444263.
30. Cooper C, Guo J, Yan Y, Chooniedass-Kothari S, Hube F, Hamedani MK, Murphy LC, Myal Y, Leygue E. Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotides. Nucleic Acids Res 2009, 37:4518-4531. 19483093, 2715257, 10.1093/nar/gkp441.
31. Yeh ET. SUMOylation and De-SUMOylation: wrestling with life's processes. J Biol Chem 2009, 284:8223-8227. 10.1074/jbc.R800050200, 19008217.
32. Zhao J. Sumoylation regulates diverse biological processes. Cell Mol Life Sci 2007, 64:3017-3033. 10.1007/s00018-007-7137-4, 17763827.
33. Green A, Burney C, Granger C, Paish E, El-Sheikh S, Rakha E, Powe D, Macmillan R, Ellis I, Stylianou E. The prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome. Breast Cancer Research and Treatment 2008, 110:427-437. 10.1007/s10549-007-9737-y, 17902051.
34. Camp RL, Chung GG, Rimm DL. Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med 2002, 8:1323-1327. 10.1038/nm791, 12389040.
35. Henderson KD, Bernstein L, Henderson B, Kolonel L, Pike MC. Predictors of the timing of natural menopause in the multiethnic cohort study. Am J Epidemiol 2008, 167:1287-1294. 10.1093/aje/kwn046, 18359953.
36. Menopause practice: a clinician's guide. 2007, The North American Menopause Society: Cleveland.